Montara Therapeutics Closes $8 Million Seed Round to Develop Safer, More Effective Neuroscience Drugs Using a Novel Brain-Only Pharmacology Approach

Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the closing of an oversubscribed $8 million seed financing led by SV Health Investors’ Dementia Discovery Fund and co-lead Two Bear Capital. Dolby Family Ventures and KdT Ventures also participated in the round. 

UCSF Innovation Ventures congratulates Martin Kampmann and Kevan Shokat, the co-scientific founders!

More